Bill > S1102

This bill mandates that various health insurers in New Jersey, including hospital and medical service corporations, commercial health insurers, health maintenance organizations (HMOs), and plans under the Individual Health Coverage and Small Employer Health Benefits Programs, as well as the State Health Benefits Program and the School Employees' Health Benefits Program, must provide coverage for the purchase and use of a continuous glucose monitoring system when prescribed by a healthcare professional for the treatment of glycogen storage disease, a rare genetic disorder affecting how the body stores and uses sugar. This coverage requirement applies to new and renewed policies and contracts issued or approved after the bill's effective date, ensuring that these systems are covered to the same extent as other medical conditions under the respective plans.

Business and Industry

https://www.njleg.state.nj.us/bill-search/2026/S1102